SOX9 and gastric cancer: In gastric cancer, the role of genomic alterations in PM development remains controversial: TCGA analyses revealed limited oncogenic pathway alterations in PM30, while Tanaka et al. reported enrichment of CDH1, SOX9, and EGFR in gastric PM versus primary tumors31.